COA of Formula: C7H9N, Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. 108-47-4, Name is 2,4-Dimethylpyridine,belongs to chiral-nitrogen-ligands compounds, now introducing its new discovery.
The benzazole compounds of this invention can be represented by the following formula [I]: STR1 wherein R 1 is aryl or a heterocyclic group, each of which may have suitable substitutent(s),< P>
R 2 is hydroxy, mercapto, lower alkylthio, sulfo, lower alkyl, amino or substituted amino,
R 3 is hydrogen, halogen or lower alkoxy,
A is lower alkenylene, lower alkylene optionally substituted with hydroxy, or a group of the formula:
–A’–Q–A”–,
in which A’ is lower alkylene, A” is lower alkylene or a single bond, and Q is O or S, and
< P>X is O, S, NH or N–R 4, in which R 4 is lower alkyl,< P>
More particularly, it relates to benzazole compounds and pharmaceutically acceptable salts thereof which have antiulcer activity and H 2-receptor antagonism, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the treatment of ulcers in human being or animals. ”
In conclusion, we affirm that quantitative kinetic descriptions of catalytic behavior continue to serve as an indispensable tool to navigate research efforts intended to model. If you are interested in 108-47-4, you can contact me at any time and look forward to more communication. COA of Formula: C7H9N
Reference：
Chiral nitrogen ligands in late transition metal-catalysed asymmetric synthesis—I. Addressing the problem of ligand lability in rhodium-catalysed hydrosilations,
Nitrogen-Containing Ligands for Asymmetric Homogeneous and Heterogeneous Catalysis